S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
NASDAQ:DOMH

Dominari - DOMH Stock Forecast, Price & News

$3.36
+0.11 (+3.38%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.28
$3.37
50-Day Range
$2.98
$4.45
52-Week Range
$2.88
$10.20
Volume
27,633 shs
Average Volume
30,608 shs
Market Capitalization
$18.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

DOMH stock logo

About Dominari (NASDAQ:DOMH) Stock

Dominari Holdings, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

DOMH Stock News Headlines

Dominari (DOMH) Scheduled to Post Quarterly Earnings on Monday
See More Headlines
Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

DOMH Company Calendar

Today
3/26/2023
Next Earnings (Estimated)
3/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DOMH
Web
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-7,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$19.27 per share

Miscellaneous

Free Float
5,013,000
Market Cap
$18.45 million
Optionable
Not Optionable
Beta
0.96

Key Executives

  • Anthony C. Hayes
    Director, Chief Executive & Financial Officer
  • Christopher Devall
    Chief Operating Officer
  • Darrell Dotson
    Vice President-Drug Development & General Counsel













DOMH Stock - Frequently Asked Questions

How have DOMH shares performed in 2023?

Dominari's stock was trading at $3.28 at the beginning of the year. Since then, DOMH stock has increased by 2.4% and is now trading at $3.36.
View the best growth stocks for 2023 here
.

When is Dominari's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our DOMH earnings forecast
.

What is Dominari's stock symbol?

Dominari trades on the NASDAQ under the ticker symbol "DOMH."

How do I buy shares of Dominari?

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dominari's stock price today?

One share of DOMH stock can currently be purchased for approximately $3.36.

How much money does Dominari make?

Dominari (NASDAQ:DOMH) has a market capitalization of $18.45 million. The company earns $-7,170,000.00 in net income (profit) each year or ($3.8805) on an earnings per share basis.

How can I contact Dominari?

Dominari's mailing address is One Rockefeller Plaza, 11Th Floor, New York, New York 10020. The company can be reached via phone at (112) 745-1374, via email at investorrelations@aikidopharma.com, or via fax at 703-992-9348.

This page (NASDAQ:DOMH) was last updated on 3/26/2023 by MarketBeat.com Staff